Harbour Investments, Inc. Agenus Inc Transaction History

Harbour Investments, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 15, 2023	BUY	$2.02 - $3.25 $1,010 - $1,625	500 New	500 $1,000
Q4 2021 Feb 16, 2022	SELL	$2.92 - $5.74 $554 - $1,090	-190 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$4.98 - $6.63 $4,980 - $6,630	-1,000 Reduced 84.03%	190 $1,000
Q1 2021 Aug 17, 2021	BUY	$2.69 - $5.25 $3,201 - $6,247	1,190 New	1,190 $3,000

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Harbour Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Harbour Investments, Inc. with notifications on news.